Philadelphia Pharmaceuticals logo

Philadelphia Pharmaceuticals (PHIL)

ASE

Philadelphia Pharmaceuticals

USD
1
Board Size
0
Announcements (30d)
None on file
13.7x
P/E Ratio

Company Overview

Ticker: PHIL
Exchange: ASE
Sector: -
Industry: -
Market Cap: $16M
Currency: USD
FY End: December
Accounting Standard: -
Employees: -

Leadership team data not yet available for this company.

We're expanding our GCC coverage — check back soon.

Recent Announcements

No announcements yet.

Data Sources

Financials (1 yrs)
Dividends (5)
Board (1) + 3 officers/formerJsc Darb Haiku
Prices (1,000 days)3208d

See Data Freshness Monitor for platform-wide data quality.

Price Chart

Insufficient price data

Key Metrics

P/E Ratio13.69
P/B Ratio-
EV/EBITDA-
Dividend Yield-
ROE6.3%
ROA-
Net Margin9.4%
Debt/Equity0.28
Net Debt/EBITDA-
FCF Yield-

Governance Score

—

Insufficient data

2/12 dimensions populated

Dividend Safety

F

10/100

Accounting Quality

B

75/100

Caution: M-Score elevated

SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.

Data sources · Full disclaimer · Data freshness

Frequently Asked Questions about Philadelphia Pharmaceuticals

Where is Philadelphia Pharmaceuticals listed?

Philadelphia Pharmaceuticals is listed on the Amman Stock Exchange (ASE) under the ticker PHIL. SouqData profiles its financials, board and shareholders from public exchange disclosures.

What is the market cap of Philadelphia Pharmaceuticals?

Philadelphia Pharmaceuticals (ASE: PHIL) has a market capitalisation of about $16M (USD), according to the latest market data held by SouqData. The figure moves daily with the share price.

How many directors are on the Philadelphia Pharmaceuticals board?

Philadelphia Pharmaceuticals has 1 current board member on record at SouqData, according to the latest board data drawn from public disclosures.

Pro Plan

Unlock the full SouqData platform

Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.

Full ScreenerAI CopilotDeep Research